Oxford Bioscience Partners
Company Information
Boston, MA
United States
Phone: 1 617 357 7474
Fax: 1 617 357 7476
Overview
Oxford Bioscience Partners (OBP) is a life science venture capital firm that provides equity financing and management assistance to advanced-stage start-ups and later-stage commercially oriented organizations. The General Partners of OBP currently manage venture funds with combined committed capital of more than $800 million. The objective of Oxford Bioscience Partners is to generate long-term capital gains for both the investors in the Fund and the entrepreneurs that we support. To meet this goal, we invest in businesses capable of improving the diagnosis and treatment of disease, as well as companies with technologies that accelerate drug discovery and development.
Corporate Structure
CHIEF EXECUTIVE OFFICER
TOP EXECUTIVES
Jeffrey T Barnes General Partner
Michael J. Magliochetti Entrepreneur-in-Residence
Alexia Pearsall Controller
Raymond Charest Chief Financial Officer
Ellen S Baron Partner
Matthew A Gibbs General Partner
Omar Amirana Investment Manager
Robert Kamen Executive, In
Mark P Carthy General Partner
Christopher Mirabelli Chair
Steven D Targum Executive, In
Monika A Vnuk
Michael R Pavia Entrepreneur-in-Residence
Soon H Lee Analyst
Edmund M Olivier Founding General Partner
Ted W Love
David Poorvin Executive, In
John R Cullinane Jr Investment Manager
Jonathan Fleming Managing Partner
Axel Unterbeck Executive, In
Pooja S Pathak Analyst
Manuel Navia Executive-In-Residence
David Armistead Executive
Pei Ho Analyst
Cornelius T Ryan Founder
Michael Lytton General Partner
Douglas Fambrough Partner
Alan G. Walton General Partner
David K. Bol General Partner
Michael J. Pavia Entrepreneur-In-Residence
J Christopher Flaherty Executive Vice President, Technology and Intellectual Property
George N Hatsopoulos Director
Kimi E. Iguchi Vice President, Finance
Oded Ben-Joseph Executive-In-Residence, Boston, MA
Theo Melas-Kyriazi Director
Kathleen Moeckel Office Manager
Nicholas G Hatsopoulos Director
Jon P Joseph Vice President, R&D and Applications Development
Philip W Morgan Director
John P. Donoghue Chief Scientific Officer, Director
Lisa Jordan Principal
Daniel E Geffken Director
